广州市肾细胞癌医保患者直接经济负担研究

摘要

Objectives To evaluate the disease economic burden of renal cell carcinoma (RCC)from a social point.Methods The study used the 2010-2012Medical Insurance Database from Guangzhou to calculate the direct e-conomic burden of RCC and carried on influencing factor analysis by classification trees.Results From 2010 to 2012,Guangzhou's direct medical costs of RCC were 4.30 million yuan,7.07 million yuan and 11.31 million yuan.Outpatients'drug costs occupied 47% of the total medical expenses and this number for inpatients was 46%.Inpatients'total medical expenses occupied 98% of the direct economic burden of RCC.Gender and age of patients had a greater influence on the total medical costs.Hospitalization days and whether to operate of hospitalized patients had greater influence on the total medical costs.Conclusions Attendances increased year by year due to RCC and the direct economic burden increased significantly.%目的 从社会角度探讨广州市肾细胞癌疾病经济负担情况.方法 对广州市2010—2012年有关肾癌医保患者数据进行描述性统计分析,计算肾癌的直接经济负担,利用分类树进行影响因素分析.结果 2010—2012年广州市肾癌患者的直接经济负担分别是430万元、707万元、1131万元.肾癌门诊患者和住院患者的药品费用分别占总医疗费用的47%和46%.住院患者的总医疗费用占肾癌直接经济负担的98%.肾癌患者的就诊类型、性别、年龄对总医疗费用影响较大.性别和年龄对门诊患者的次均总医疗费用影响较大,住院天数和是否手术对住院患者的次均总医疗费用影响较大.结论 肾癌就诊人次逐年增多,直接经济负担也明显上升.